For STAT News's report this month, the headline fact was simple: Bon Secours Mercy Health, the Catholic nonprofit system based in Cincinnati, has received about $1.1 billion this year from its minority stake in Ensemble Health Partners, the medical billing firm it once owned outright. The first payment was a $427 million distribution recorded in February. The second was a $671 million payment that arrived about two weeks before the report ran, after Ensemble signed with a new private equity sponsor. Both appear on the system's financial statements for the second quarter, which ended June 30.
The comparison that gives the numbers their edge is the one STAT drew in its subhead: the payouts exceed the system's operating income for the year so far. A nonprofit chain that runs dozens of hospitals made less money from caring for people this year than it made from a billing company's distributions. "For Bon Secours Mercy Health, Ensemble Health Partners is the gift that keeps on giving," the article opens. The question the ledger raises but does not answer is where the gift comes from, and who sits on the other side of it.
The short answer is that the payouts are the output of a machine the system built and then sold pieces of, and the machine's feedstock is the money patients owe after insurance. Following the ownership chain makes the structure visible.
Every change of owner pays the ministry again
The system's stake has now outlived three private equity ownership eras. In May 2019, Bon Secours Mercy sold 51 percent of Ensemble, which had begun as its in-house billing and collections operation, to Golden Gate Capital in a deal reported at the time to bring the system about $1.2 billion in cash. The system kept a minority stake, a board seat, and a commercial relationship, and its own 2019 announcement said the proceeds would support continued investment in the communities the ministry serves.
In March 2022, Berkshire Partners and Warburg Pincus invested in Ensemble, with Golden Gate retaining a minority position. This June, Thoreau, the healthcare investment platform founded by Matt Holt and backed by Apollo, signed a definitive agreement to make a strategic growth investment in the company, in a deal that reports valued at roughly $12 billion. Bon Secours Mercy continues as a shareholder under all three arrangements, according to the Berkshire Partners announcement.
That history explains the odd shape of this year's payments. The $671 million did not arrive as an operating distribution; it arrived because Ensemble changed owners, the kind of event a minority holder is positioned to cash in on each time it happens. The stake has become a claim that pays out on ownership transitions as well as on operations. The system collects whether the firm is run by one sponsor or the next, and every new deal lets the incoming owners reset the value of the business upward, which is what the reported $12 billion figure represents.
The billing department that grew into the owner's biggest customer
The deeper wrinkle is that Bon Secours Mercy is not only the seller and the minority owner. It is also a client. The 2019 deal kept the system on as a commercial partner, meaning Ensemble continued to run billing and collections for the system's own hospitals, the same work the operation did when it sat inside the system.
How much that mattered was visible in 2021, when Ensemble filed to go public. In the company's SEC registration statement, Bon Secours Mercy accounted for 65 percent of Ensemble's net revenue in the first half of 2020 and 51 percent in the first half of 2021. The firm's largest book of business was the patient billing of the organization that owned its minority shares. Owner and customer were the same party, and the party's own patients were the feedstock.
That is what makes the $1.1 billion something other than ordinary investment income. The entity paying the system is the company that stands between hospitals and their money. Ensemble describes its work as the full revenue cycle: patient access, coding, claims, denial prevention, accounts receivable follow-up, and the patient financial experience, which is industry language for collecting the portion of the bill patients owe. The firm says it manages more than $55 billion in net patient revenue across more than 200 hospitals.
Patient balances are the fuel in the engine
Revenue cycle firms are paid for the cash they bring in, and in the standard outsourcing model the fee scales with the dollars collected. As health plans have pushed costs onto patients through high deductibles and coinsurance, the patient's share of the hospital bill has grown into a major revenue line for hospitals and, by extension, for the firms that collect it. A distribution like February's $427 million is a share of the profits of that business. The money flowing into the nonprofit system's statements and the balances sitting on patients' bills are the same river, seen at different points along it.
The scale of what patients owe is well documented. KFF's analysis of medical debt found that people in the United States owe at least $220 billion in medical debt, that about 20 million adults, nearly one in twelve, currently owe on unpaid medical bills, and that roughly 3 million owe more than $10,000. Under a broader measure that counts credit card debt and money owed to family, 41 percent of adults carry health care debt. The burden falls unevenly: it is more common among Black adults, among people in the South, and among people in poor health or with disabilities, and it is not explained by how carefully households budgeted.
None of this means the payouts are improper. Ensemble does not buy defaulted accounts and chase consumers; it bills and collects for hospitals, many of them nonprofits with their own financial assistance policies, and revenue cycle outsourcing is a standard, mainstream part of American healthcare finance. Judson Ivy, Ensemble's founder and chief executive, said in June that the firm sees "tremendous opportunity to reduce the friction in healthcare for providers, patients, and everyone involved." The friction reduction, though, is measured in dollars recovered, and the incentives point the same direction for the firm, its private equity owners, and the nonprofit system holding the minority stake: the larger the collected total, the larger the payouts.
The margin the payouts rescue is the same one they test
The context that makes the arrangement feel inevitable is that hospitals are struggling to make money. Kaufman Hall's hospital finance reporting, which tracks more than 1,300 hospitals, shows median operating margins hovering around 2 percent this year, below their 2025 levels, with uncompensated care up sharply in early 2026 as patients shifted into government programs and high-deductible plans. Boards and rating agencies have pressed systems of all kinds to diversify revenue, and a minority stake in a fast-growing billing firm is exactly the kind of non-patient income stream finance committees want to see.
Bon Secours Mercy's case is straightforward and defensible. The system built the business, sold half of it at a high price, kept a slice, and is now being paid for an asset it created, with the proceeds available for its charitable work. The 2019 announcement said the cash would support the ministry's investment in its communities. If the payouts help keep hospitals open and staffed in the economically struggling areas the system serves, that is mission, not rent-seeking. This analysis takes no position on whether the system should keep its stake or on whether the payouts help or hurt the ministry's work.
What is harder to wave away is the direction of the dependency. The system's operating income for the year has been matched, and then exceeded, by distributions from a company whose revenue grows with how much it collects. The more of the bill that gets recovered, the better the stake performs, and patient responsibility is a growing share of what gets recovered. A nonprofit health system is now, in part, a claim on its patients' out-of-pocket payments, held alongside private equity firms whose portfolios contain other pieces of the same industry. Ensemble is one of roughly two hundred revenue cycle companies in private equity or venture hands as of mid-2024, by TechTarget's reporting, and the pattern is not unique to this deal. Hospital cash flow and patient debt meet in a single ledger all across the industry.
The two ends of one mechanism
So who captures the benefit, and who bears the cost? The benefit is split several ways across the structure. The private equity sponsors capture it through management fees and eventual exits. The nonprofit system captures it through distributions and sponsor-change payments like the $671 million. Ensemble's leadership captures it through a firm that has grown from a hospital department into a business reportedly worth $12 billion. On the other side sit the patients whose balances fund the enterprise, and, less visibly, the mission itself: a system whose cash flow depends on collecting from patients faces a standing incentive that its charitable statements do not address.
The reframe is simple. The $1.1 billion was not found money, and it was not created by the transaction that released it. It is the capitalized value of the business of collecting what patients owe, converted into cash each time the ownership changes hands, which is why the numbers look so large in a single year. The same dollar appears twice in this story: once as the balance on a patient's statement, once as the distribution on the system's income statement. The gift and the bill are the same number, seen from opposite ends of the billing process. Whatever one thinks of the arrangement, everyone involved should be able to agree that the ledger should be transparent.
Primary sources
- STAT News reporter Tara Bannow's August 18, 2026 article for the payout figures and the comparison to the system's operating income.
- Bon Secours Mercy Health's May 2019 announcement for the terms of the Golden Gate transaction and the system's stated use of proceeds.
- Berkshire Partners' June 2026 announcement for the Thoreau investment details, the description of Ensemble's business, and Judson Ivy's remarks, and TechTarget's reporting for the reported $12 billion valuation and industry context on private equity ownership of revenue cycle companies.
- Ensemble's 2021 SEC registration statement for the revenue concentration figures, KFF's medical debt analysis for the debt statistics, and Kaufman Hall's reporting for the hospital operating margin data.